News

Vivasure Medical Announces Launch of the PerQseal® Large-Bore Closure Device

The world’s first fully absorbable, patch-based large-bore percutaneous closure device is now available to European physicians and patients. More...

09 November 2018

Vivasure Medical to exhibit at PCR London Valves

Vivasure Medical will be exhibiting at PCR London Valves which takes place at The ExCel, London Docklands, from 9-11 September. Vivasure will occupy booth # 21 where it will demonstrate the PerQseal® large hole vascular closure device. More...

31 August 2018

Vivasure Medical to exhibit at EuroPCR 2018

Vivasure Medical will be exhibiting at EuroPCR in Paris. This year we will be hosting a demonstration suite on our booth offering attendees hands-on experience of the PerQseal® large arteriotomy closure device and an opportunity to talk to our technology experts. More...

14 May 2018

Vivasure Medical to exhibit at JIM 2018

Vivasure Medical is pleased to announce that it will exhibit its PerQseal® vascular technology at JIM 2018, which will take place at The Milan Marriott Hotel, Milan, Italy from February 22nd–24th. Vivasure will be at booth 15 on the main exhibition floor. More...

13 February 2018

Vivasure Medical to exhibit at LINC 2018

Vivasure Medical is pleased to announce that it will exhibit its PerQseal® vascular technology at LINC 2018, which will take place at The Trade Fair in Leipzig, from January 30th – February 2nd. Vivasure will be at booth 37 on the main exhibition floor. More...

19 January 2018

Vivasure Medical to exhibit at TCT 2017

Vivasure Medical will exhibit its PerQseal® vascular technology at TCT 2017, which will take place at Colorado Convention Center in Denver, CO, USA, from October 29th - November 2nd. Vivasure will be at booth 4134 on the main exhibition floor. More...

20 October 2017

Vivasure Enrolls First Patient in Frontier IV Clinical Trial

Vivasure Medical is pleased to announce the successful enrollment of the first patient in the Frontier IV clinical study, a non-randomized multicenter international trial, designed to expand the indications of its proprietary PerQseal® large arteriotomy closure technology. The patient was enrolled by Dr. Peter Crean at the Blackrock Clinic, Dublin, Ireland. More...

13 October 2017

Vivasure Medical to present their PerQseal technology at PCR London Valves 2017

Vivasure Medical is pleased to announce that Dr. Michael Laule, from the Charite Hospital in Berlin Germany, will deliver a presentation on its PerQseal technology on Monday 25th September at 17:20h during the session “Percutaneous valve intervention: new devices, new approaches” at PCR London Valves, which will be held at London’s ExCel from 24th -26th September2017. Vivasure will also be exhibiting at the congress. More...

19 September 2017